Phenylephrine is used in popular versions of Sudafed, Dayquil, and other medications, but experts have long questioned its effectiveness. Last month the Food and Drug Administration formally proposed ...

After the FDA proposed pulling some over-the-counter cold and flu medications from shelves in the US, an Australian law firm ...

And two weeks ago, the FDA officially proposed removing it as an active ingredient in oral over-the-counter drugs for nasal congestion. The ingredient is called phenylephrine, and it was only ...

Pharmaceutical giant Johnson & Johnson has been accused of knowingly marketing and selling ineffective nasal decongestant ...

That's where the class of medications known ... The other reason: Phenylephrine is technically approved by the Food and Drug ...

The class action pertains to tablets in products such as Codral Day and Night and Sudafed PE that contain a substance called phenylephrine. The US Food and Drug Administration (FDA) last year ...

Sick customers who bought some cold and flu medications have been falsely assured their nasal congestion would be relieved, ...

A class action has been filed against ... The action relates to tablets containing phenylephrine, a substance which the US Food and Drug Administration (FDA) last year declared was not an ...

Publicly accessible research casting doubt about the effectiveness of an ingredient in popular cold and flu tablets has been ...

We now have compelling convincing evidence that oral phenylephrine is ineffective at relieving symptoms of nasal congestion. I feel that this drug and this oral dose shouldn't, um, should have ...

CANBERRA, Dec. 21 (Xinhua) -- An Australian law firm has launched a class action lawsuit against U.S. pharmaceutical giant Johnson & Johnson, accusing it of selling ineffective medicines.